In May 1993, a pulmonary disease syndrome with novel clinical and epid
emiologic features was identified in the southwestern United States. H
ealthy young adults developed a febrile prodrome followed by the rapid
onset of often lethal acute respiratory distress. Although an infecti
ous disease was suspected, intensive investigations initially failed t
o identify the causative agent. Multiple specialized microbiology labo
ratories in a national reference center applied classic serologic and
culture methods as well as recently developed molecular biological tec
hniques to samples collected from field investigations of the patients
. Serologic tests detected the presence of an active immune response t
o a hantavirus. Reverse transcription and polymerase chain reaction am
plification of RNA extracted from human tissues used primers designed
from sequences of known hantaviruses to demonstrate genomic sequences
of a novel hantavirus. Immunohistochemistry showed the presence of han
tavirus antigens in the endothelium of lung tissues from patients and
provided a final pathogenetic link to this group of viruses. These met
hods were concordantly positive in virtually all samples available fro
m 18 patients with compatible clinical histories identified between Ja
nuary and July 1993. Tests of control subjects and searches for other
agents in identified cases were negative. A newly recognized hantaviru
s causes a novel syndrome of acute pulmonary edema and shock; the path
ogenesis is related to the presence of virus antigens in the pulmonary
capillaries. This virus may be an important cause of severe and fatal
disease presenting as adult respiratory distress syndrome in otherwis
e healthy persons. The Centers for Disease Control in collaboration wi
th state and local health departments has begun a national surveillanc
e program to determine the incidence of this newly described disease a
nd is coordinating longitudinal and wider geographic studies of the na
tural history virus-rodent relationship.